Skip to Content
Merck
All Photos(1)

Documents

20018AST

Supelco

Astec® CYCLOBOND I 2000 Chiral (5 μm) HPLC Columns

L × I.D. 10 cm × 2.1 mm, HPLC Column

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52

product name

Astec® CYCLOBOND I 2000 Chiral HPLC Column, 5 μm particle size, L × I.D. 10 cm × 2.1 mm

material

stainless steel column

product line

Astec®

packaging

pkg of 1 ea

manufacturer/tradename

Astec®

parameter

0-50 °C temperature
172 bar pressure (2500 psi)

technique(s)

HPLC: suitable
LC/MS: suitable

L × I.D.

10 cm × 2.1 mm

matrix

silica particle platform

matrix active group

cyclodextrin, beta- phase

particle size

5 μm

pore size

100 Å

operating pH

3.5-7

separation technique

chiral

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

CYCLOBOND I 2000 is bonded with β-cyclodextrin by a patented process to produce a stable matrix with the cyclodextrin arranged in such a way as to retain its most valuable property of forming inclusion complexes. This allows them to effect numerous chemical separations by selectively including into their cavities a wide variety of organic molecules. Non-inclusion type separations are also possible with the polar organic mode for a wide variety of molecule types.

  • Bonded phase: Underivatized, native β-cyclodextrin

Resources:
CYCLOBOND FAQs
CYCLOBOND Reference Bibliography
Chiral Product Literature

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
288756-01
280947-01
274689-01
269111-01
269107-01

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A F Casy et al.
Journal of pharmaceutical and biomedical analysis, 9(10-12), 787-792 (1991-01-01)
The interaction of beta-cyclodextrin with a series of structurally related chiral thromboxane antagonists was investigated using NMR and RP-HPLC. HPLC studies used both a cyclodextrin bonded phase (Cyclobond I), and beta-cyclodextrin as a mobile phase additive with an achiral C8
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids
Geisslinger, G., et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 491, 139-149 (1989)
Chiral separations of ?-blocking drug substances using chiral stationary phases
Ekelund, Jens, et al.
Journal of Chromatography A, 708 (2), 253-261 (1995)
Chiral separation of 3-phenyl-3-(2-pyridyl)propylamines, and analogous guanidines and guanidine-N-carboxylic acid esters with high-performance liquid chromatography and capillary zone electrophoresis
Schuster, Andreas, et al.
Journal of Chromatography A, 793 (1), 77-90 (1998)
Liquid chromatographic resolution of enantiomers of deltahedral carborane and metallaborane derivatives
Plesek, Jaromir, et al.
Journal of Chromatography A, 626 (2), 197-206 (1992)
View All Related Papers

Related Content

Astec CYCLOBOND™

CYCLOBOND is the name given to Astec technology for bonding cyclodextrins to a high purity silica gel through a stable ether linkage.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service